INRATIO2
Report
- Report Number
- 2027969-2011-02014
- Event Type
- Malfunction
- Date Received
- September 26, 2011
- Date of Event
- August 23, 2011
- Report Date
- September 26, 2011
- Manufacturer
- ALERE SAN DIEGO, INC.
- Product Code
- GJS
- PMA / PMN Number
- K072727
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NV, US
- Reporter Occupation
- NOT APPLICABLE
Narratives
NO DATA ANALYSIS WAS PERFORMED BECAUSE CUSTOMER WAS TAKING LOVENOX. LOVENOX IS A CLASS OF ANTITHROMBOTIC AGENTS KNOWN AS LOW-MOLECULAR-WEIGHT HEPARINS (LMWH). PER PRODUCT USER GUIDE - LIMITATIONS, "THIS TEST SHOULD NOT BE USED FOR PTS ON HEPARIN THERAPY." RECENT TEST CONDUCTED ON LOT 253023 ON 09/16/2011 MET BOTH ACCURACY AND PRECISION CRITERIA. TEST RESULTS ARE AS FOLLOWS: DONOR 104 = 3.3, 3.3, 3.1 INR; DONOR 105 = 2.9, 2.9, 2.9 INR. AT LEAST TWO OUT OF THREE REPLICATES ARE WITHIN THE ALLOWABLE BIAS (+ OR - 1.0) OF REFERENCE RESULTS FOR DONOR 104 (3.20 INR) AND DONOR 105 (2.38 INR), RESPECTIVELY. IN-HOUSE TEST RESULTS HAVE 3.57% AND 0.00%, RESPECTIVELY FOR EACH DONOR AND ARE LESS THAN 16% CV. NO FURTHER INVESTIGATION WILL BE PURSUED AT THIS TIME.(B)(4). DUE TO THIS LOW OCCURRENCE RATE, BELOW THE ACTION THRESHOLDS MONITORED BY QA FOR CORRECTIVE ACTION, NO FURTHER ACTION IS REQUIRED AT THIS TIME. NO CORRECTIVE ACTION REQUIRED AT THIS TIME AS NO PRODUCT DEFICIENCY WAS ESTABLISHED.
CUSTOMER ALLEGES DISCREPANT RESULTS WITH METER COMPARED TO LAB: DATE: UNK; INRATIO: 5.9; LAB: UNK. DATE: (B)(6) 2011; INRATIO: 5.8; LAB: UNK. UNK DATE WAS STATED TO BE "ABOUT A WEEK AGO" ON (B)(6) 2011. THE LAB INR RESULT ON THIS DATE WAS STATED TO BE >10. THE LAB INR VALUE ON (B)(6) 2011 WAS STATED TO BE >8. CUSTOMER DID NOT HAVE EXACT INR LAB RESULTS, BUT THOUGHT THAT THESE WERE AROUND THE RIGHT VALUE. LAB DRAWS WERE PERFORMED WITHIN MINUTES OF METER RESULTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | INRATIO2 | PROTHROMBIN TIME TEST | GJS | ALERE SAN DIEGO, INC. | 100139 | 253023 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |